Concepedia

Virginia Pascual‐Ramos

VP

36

Publications

1.6K

Citations

21

H-Index

2004

Active since

Affiliations

Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán(Current)

Harbor–UCLA Medical Center

Diakonhjemmet Hospital

Dudley Group NHS Foundation Trust

University of Manitoba

Virginia Pascual‐Ramos is an author at Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán specializing in medicine, hearing loss, and rheumatic diseases.

ORCID

Top concepts

Publications per year

2004–2024

36

Publications

36

A phase IIb dose‐ranging study of the oral JAK inhibitor tofacitinib (CP‐690,550) versus placebo in combination with background methotrexate in patients with active rheumatoid arthritis and an inadequate response to methotrexate alone

Joel M. Kremer, Stanley Cohen, Bethanie Wilkinson et al. · Arthritis & Rheumatism · 2011 · 343 citations · Full text

Rheumatoid arthritis-specific cardiovascular risk scores are not superior to general risk scores: a validation analysis of patients from seven countries

Cynthia S. Crowson, Sherine E. Gabriel, Anne Grete Semb et al. · Lara D. Veeken · 2017 · 137 citations · Full text

Medication persistence over 2 years of follow-up in a cohort of early rheumatoid arthritis patients: associated factors and relationship with disease activity and with disability

Virginia Pascual‐Ramos, Irazú Contreras-Yáñez, Antonio Villa et al. · Arthritis Research & Therapy · 2009 · 93 citations · Full text

Systemic lupus erythematosus as a cause and prognostic factor of acute pancreatitis.

Virginia Pascual‐Ramos, Andrés Duarte‐Rojo, Antonio Villa et al. · PubMed · 2004 · 92 citations

Infections in patients with rheumatoid arthritis receiving tofacitinib versus tumour necrosis factor inhibitors: results from the open-label, randomised controlled ORAL Surveillance trial

Andra Bălănescu, Gustavo Citera, Virginia Pascual‐Ramos et al. · Annals of the Rheumatic Diseases · 2022 · 62 citations · Full text

Rows per page

1–5 of 36